Medical marijuana and organ transplants don’t mix
Medical marijuana and organ transplants don’t mix - Los Angeles Times
SEATTLE — This month, Timothy Garon, 56, a Seattle musician, died after being turned down for a liver transplant. He was rejected partly because he had used medical marijuana.
Now, a second critically ill patient in Washington state says he has been denied a spot in two organ transplant programs because he uses doctor-prescribed marijuana.
Jonathon Simchen, 33, of Fife, a town south of Seattle, is a diabetic whose kidneys and pancreas have failed.
He said he was removed from the transplant program at Virginia Mason Hospital in Seattle because he admitted using medical marijuana. Later, he said, University of Washington Medical Center transplant officials refused to accept him because of the medical marijuana issue.
The lawyer who represented Garon has taken on Simchen’s case.
Douglas Hiatt argues that his clients are the victims of a loosely defined transplant policy, one not based on science.
University of Washington officials, citing privacy laws, declined to discuss specifics of individual cases, but issued a statement acknowledging that they took marijuana use into consideration.
“Although medical marijuana may be an issue in rare cases, it is never the sole determinant in arriving at medical decisions about candidates for organ transplants,” the statement said.
A spokeswoman for Virginia Mason Hospital said smoking of any kind could “lead to patient-safety and transplant-effectiveness issues” and was precluded. She said the hospital’s transplant committee would also weigh a patient’s use of medical marijuana in pill form.
At the University of Washington, the transplant committee said it reviewed “behavioral concerns such as a history of substance abuse or dependency. If such a history exists, then the committee looks at the period of abstinence the candidate has demonstrated to date,” as well as the patient’s efforts to maintain abstinence and potential to abuse again.
Asked why the committee considered marijuana use under a doctor’s supervision “a history of substance abuse,” a hospital spokesman cited the federal law categorizing marijuana as an illegal drug.
Peggy Stewart, a clinical social worker with the liver transplant program at UCLA Medical Center, said bias existed in the medical community against marijuana because of the federal law.
Some transplant committee members see it as an illegal substance and as grounds for automatic rejection.
She said many other addictive prescriptions, particularly pain medications, did not automatically disqualify patients from transplant lists because they were not illegal substances under federal law.
It’s bad because it’s illegal because it’s bad because it’s illegal because it’s bad because it’s illegal…
It is simply beyond my ability to process the outrage of this ignorant cowardice! Medical professionals will knowingly divert the frailest patients from the safe non-toxic herb and onto the dangerous addictive pharmaceuticals, and then hide behind the government’s skirts? Ooh, it’s against federal law? Your state doesn’t think so, members of your profession are recommending it, and your oath is to first do no harm!
Furthermore, that one official says they’d even “weigh” use of medical marijuana in pill form. That’s called Marinol, and it isn’t against federal law.
As for the “patient safety and transplant-effectiveness” issues, you don’t have any evidence to back that up. Vaporization or edibles eliminate the problems with smoking. Post transplant there is no “addictiveness” in the serious physical sense of the word to jeopardize transplant-effectiveness.
This is nothing more than institutionalized discrimination against a disliked minority, only this isn’t about the color of their skin but rather the color of their medicine.
Tags: Douglas Hiatt, Jonathon Simchen, Seattle, Tim Garon, transplant, Washington
